期刊文献+

RNA干扰糖原合成激酶-3β对胰腺癌细胞生长的抑制作用 被引量:2

Glycogen synthase kinase-3β RNA interference suppresses growth of pancreatic adenocarcinoma cells
原文传递
导出
摘要 目的观察沉默糖原合成激酶-3p(GSK-3p)对人胰腺癌细胞株PANC-1增殖和存活的影响,探讨其分子机制。方法实验分组如下:阴性对照组为未转染的PANC一1细胞;载体对照组为稳定转染control shRNA的PANC-1细胞;实验组为稳定转染GSK-3β shRNA的PANC.1细胞。噻唑蓝(MTF)比色法连续7d检测各组细胞的吸光度(A)值,并绘制出细胞的生长曲线;流式细胞仪(FCM)检测各组细胞的凋亡和周期;电泳迁移率实验(EMSA)检测各组细胞中核因子(NF).KB的DNA结合活性。结果转染GSK-3B短发卡RNA(shRNA)的实验组PANC.1细胞生长速度明显减慢;实验组细胞的早期凋亡比例为(5.38±0.33)%,较阴性对照组(1.71±0.08)%和载体对照组(1.68±0.11)%显著升高(P〈0.05);实验组中G0/G1期细胞比例为(60.02±1.99)%,较阴性对照组(46.56±3.13)%和载体对照组(46.04±2.92)%显著升高(P〈0.05),发生明显的G,期阻滞;实验组细胞中代表NF-KB复合体数量的条带A值为2186.37±225.51,与阴性对照组(4005.39±203.64)和载体对照组(3793.32±310.34)比较显著减少(P〈0.05);而上述对照组组间差异无统计学意义(P〉0.05)。结论靶向抑制GSK-3β可抑制胰腺癌细胞增殖,诱导其凋亡,其机制可能与下调NF-κB的转录活性有关。 Objective To investigate the effects of glycogen synthase kinase-3β (GSK-3β) RNA interference on proliferation of pancreatic adenocarcinoma cells and to explore the molecular mechanism in- volved in the procedure. Methods PANC-1 cells stably expressing GSK-3β shRNA and control shRNA served as the experimental group and the vector control group respectively, and the cells that were not transfected as the negative control group. The growth curves of PANC-1 cells were designed by MT'F assay. The apoptosis and cycle of cells were analyzed by using flow cytometry (FCM). The nuclear factor-KB (NF-κB) DNA binding activity was detected by using electrophoretic mobility shift assay (EMSA) analysis of nuclear extracts. Results As compared with control groups, the growth capability of PANC-I cells in experimental group was decreased notably. In experimental group, the early apoptosis rate [ (5.38 ± 0. 33 ) % ] was significantly higher than the negative control group [ ( 1.71 ± 0. 08 ) % ] and the vector control group [ ( 1.68 ± 0. 11 ) % ] ( P 〈 0. 05 ). In experimental group, the percentage of cells in Go and G1 phases [ (60. 02 ± 1.99) % ] was higher than in the negative control group [ (46. 56 ± 3. 13) % ] and the vector con- trol group [ (46. 04±2. 92)% ], while that in S phase cell was lower (P 〈0. 05). Cell cycle was arrest at G1 phase. In experimental group, the band intensity index which was described as the NF-KB complex number was (2186. 37 ±225. 51 ), which was lower than in the negative control group [ (4005.39 ± 203.64) ] and the vector control group [ (3793.32 ±310. 34) ], but there was no significant difference between the negative control group and the vector control group ( P 〉 0. 05 ). Conclusion GSK-313 RNA interference may inhibit the proliferation and survival of pancreatic adenocarcinoma cells via NF-KB signal pathway.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2012年第10期2032-2034,共3页 Chinese Journal of Experimental Surgery
基金 国家自然科学基金青年基金资助项目(30801098)
关键词 胰腺癌 糖原合成激酶-3B 核因子-ΚB RNA干扰 Pancreatic carcinoma Glycogen synthase kinase-313 Nuclear factor-KB RNA interference
  • 相关文献

参考文献9

  • 1Shakoori A,Ougolkov A,Yu ZW,et al. Deregulated GSK-3beta activi-ty in colorectal cancer : its asscoc.itation with tumor cell survival andproliferation. Biochem Biophys Res Commun,2005 ,334 : 1365-1373.
  • 2Ougolkov AV,Bone ND,Femandez-Zapico ME,et al. Inhibition of gly-cogen synthase kinase-3 activity leads to epigenetic silencing of nucle-ar factor kappaB target genes and induction of apoptosis in chroniclymphocytic leukemia B cells. Blood,2007 ,110:735-742.
  • 3Yamashita K,Ougolkov AV,Nakazato H,et al. Adjuvant immunoche-motherapy with protein-bound polysaccharide K for colon cancer in re-lation to oncogenic beta-catenin activation. Dis Colon Rectum, 2007,50:1169-1181.
  • 4刘特彬,崔冀,李小辉.Wnt通路关键因子在人胆管癌细胞株QBC939中的表达及其意义[J].中华实验外科杂志,2010(12):1886-1888. 被引量:11
  • 5汪理,勾善淼,周伟,王统林,刘涛,王春友.靶向人GSK-3β基因的shRNA真核表达质粒的构建及其在人胰腺癌细胞株PANC-1中的稳定表达[J].华中科技大学学报(医学版),2011,40(2):142-146. 被引量:1
  • 6Kunnumakkara AB,Diagaradjane P,Guha S,et al. Curcumin sensitizeshuman colorectal cancer xenografts in nude mice to gamma-radiationby targeting nuclear factor-kappaB-regulated gene products. ClinCancer Res,2008,14:2128-2136.
  • 7李伟,陈政,龚斐然,苗毅,陶敏,徐泽宽.蛋白磷酸酶2A抑制剂通过核因子-κB通路诱导胰腺癌细胞株PANC-1凋亡[J].中华实验外科杂志,2011,28(10):1720-1722. 被引量:4
  • 8Wang W,Abbruzzese JL,Evans DB,et al. The nuclear factor-kappa BRelA transcription factor is constitutively activated in human pancreat-ic adenocarcinoma cells. Clin Cancer Res,1999,5 :119-127.
  • 9Hoeflichh KP,Luo J,Ruble EA,et al. Requirement for glycogen syn-thase kinase-3 beta in cell survival and Nf-KappaB activation. Nature,2000,406:86-89.

二级参考文献23

  • 1于颖彦,朱正纲,严超,计俊,张俊,刘炳亚,燕敏,尹浩然,林言箴.胃癌与Wnt/β连环素信号通道活化的关系[J].中华实验外科杂志,2004,21(12):1557-1557. 被引量:12
  • 2孙备,白雪巍,孟庆辉,王刚,许军,姜洪池.核转录因子抑制剂对重症急性胰腺炎的影响[J].中华实验外科杂志,2006,23(2):179-181. 被引量:16
  • 3范跃祖,陈春球,赵泽明,孙伟.去甲斑蝥素对胆囊癌肿瘤血管生成的抑制作用[J].中华实验外科杂志,2006,23(8):922-925. 被引量:17
  • 4王曙光,韩本立,段恒春,陈意生,彭志明.肝外胆管癌细胞系的建立[J].中华实验外科杂志,1997,14(2):67-68. 被引量:66
  • 5Honkanen RE. Cantharidin,another natural toxin that inhibits the activity of serine/threonine protein phosphatases types I and 2A. FEBS Lett, 1993,330:283-286.
  • 6Wang GS. Medical uses of mylabris in ancient China and recent studies. J Ethnopharmacol, 1989,26 : 147-162.
  • 7Chen LF,Greene WC. Shaping the nuclear action of NF-KB. Nat Rev Mol Cell Biol,2004,5:392-401.
  • 8Dutta J,Fan Y, Gupta N, et al. Current insights into the regulation of programmed cell death by NF-KB. Oncogene,2006,25:6800-6816.
  • 9Miskolci V, Castro-Alcaraz S, Nguyen P, et al. Okadaic acid induces sustained activation of NF-KB and degradation of the nuclear IKBa in human neutrophils. Arch Biochem Biophys,2003,417:44-52.
  • 10Shishodia S, Aggarwal BB. Guggulsterone inhibits NF-KB and IKBcL kinase activation, suppresses expression of anti-apoptotic gene products, and enhances apoptosis. J Biol Chem, 2004,279:47148-47158.

共引文献13

同被引文献16

  • 1Shakoori A,Ougolkov A, Yu ZW,et al. Deregulated GSK-3beta activi-ty in colorectal cancer: its asscocitation with tumor cell survival andproliferation [ J ]. Biochem Biophys Res Commun,2005,334 ( 4 ):1365-1373.
  • 2Yamashita K,Ougolkov AV,Nakazato H,et al. Adjuvant immunoche-motherapy with protein-bound polysaccharide K for colon cancer in re-lation to oncogenic beta-catenin activation [ J]. Dis Colon Rectum,2007,50(8) :1169-1181.
  • 3de Araujo WM, Vidal FC,de Souza WF,et al. PI3K/Akt and GSK-3(3prevents in a differential fashion the malignant phenotype of colorectalcancer cells [ J ]. J Cancer Res Clin Oncol, 2010, 136 ( 11 ) : 1773-1782.
  • 4Tsuchiya K, Nakamura T, Okamoto R, et al. Reciprocal targeting ofHath 1 and beta-catenin by Wnt glycogen synthase kinase 3beta inhuman colon cancer[ J]. Gastroenterology,2007 ,132( 1 ) :208-220.
  • 5Erdal E,Ozturk N,Cagatay T,et al. Lithium-mediated downregulationof PKB/Akt and cyclin E with growth inhibition in hepatocellular car-cinoma cells[ J]. Int J Cancer,2005 ,115(6) :903-910.
  • 6Liao X, Zhang L, Thrasher JB, et al. Glycogen synthase kinase-3 betasuppression eliminates tumor necrosis factor-related apoptosis-indu-cing ligand resistance in prostate cancerf J]. Mol Cancer Ther,2003,2(11) :1215-1222.
  • 7Ferrara N. VEGF as a therapeutic target in cancer [ J ]. Oncology,2005,69 Suppl 3:11-16.
  • 8Kowanetz M, Ferrara N. Vascular endothelial growth factor signalingpathways : therapeutic perspective [ J ]. Clin Cancer Res, 2006, 12.17):5018-5022.
  • 9Rayasam GV,Tulasi VK,Sodhi R,et al.Glycogen synthase kinase 3:more than a namesake[J].Br J Pharmacol,2009,156 (6):885-898.
  • 10Doble BW,Woodgett JR.GSK-3:tricks of the trade for a multi-tasking kinase[J].J Cell Sci,2003,116 (7):1175-1186.

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部